Story · Nutrition

Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity

5 outlets · first reported by NEJM 4d ago · latest 17h ago · 102 hours of coverage · 2 countries

Coverage, in order

  1. 4d ago
    first NEJM indie study peer-reviewed
    Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity

    New England Journal of Medicine, Ahead of Print.

  2. 3d ago
    Everyday Health mainstream study
    Retatrutide ‘Significantly’ Eases Knee Pain in People With Obesity, Studies Show

    Buzz surrounding the drug retatrutide continues to grow, as the medication shows dramatic results in clinical trials for type 2 diabetes , obesity , and other health conditions. Retatrutide is not yet approved by the U.S. Food and Drug Administration (FDA) for use, but a growing body of research…

  3. 1d ago
    More Than Weight in Knee Pain Relief with Retatrutide?

    Once again this week new data is telling us that the benefits of treating obesity can extend well beyond weight loss. Results from a pair of clinical trials with retatrutide offers an important example, showing impressive improvements in knee pain and physical function among people living with…

  4. 18h ago
    The Medical Republic Australia indie
    Retatrutide transforms knee OA pain

    This content is for members only. Visit the site and log in/register to read.

  5. 17h ago
    Healio indie
    Weight loss with retatrutide signals ‘new days’ in osteoarthritis

    ORLANDO — Weekly injections of the GLP-1 receptor agonist retatrutide improved knee osteoarthritis pain in addition to inducing weight loss, according to data presented at ACR Convergence. “It is no news to this audience that osteoarthritis is a major problem for patients and health systems,”…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.